Annual hearing screening in children with osteogenesis imperfecta: Results from the first five years in glasgow

被引:1
作者
Lui, Emmett [1 ,4 ]
Conlan, Owen [5 ]
Hunter, Karen [2 ]
Mason, Avril [1 ,3 ]
Kubba, Haytham [1 ,4 ]
机构
[1] Univ Glasgow, Dept Child Hlth, Glasgow G12 8QQ, Scotland
[2] Royal Hosp Children, Dept Audiol, 1345 Govan Rd, Glasgow G51 4TF, Scotland
[3] Royal Hosp Children, Dept Endocrinol, 1345 Govan Rd, Glasgow G51 4TF, Scotland
[4] Royal Hosp Children, Dept Otolaryngol, 1345 Govan Rd, Glasgow G51 4TF, Scotland
[5] Univ Hosp Ayr, Dept Surg, Dalmellington Rd, Ayr KA6 6DX, Scotland
关键词
Osteogenesis imperfecta; Deafness; Hearing impairment; Screening; Audiology; COCHLEAR IMPLANTATION; EXPERIENCE; EARS;
D O I
10.1016/j.ijporl.2024.112096
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: Hearing loss is common in people with osteogenesis imperfecta (OI), although exactly how common is unknown. The prevalence of hearing loss in children with OI has been reported to be anything from 0 to 77 %. Brittle Bone Society guidelines suggest that, unless there are ear symptoms, children with OI should have their hearing tested every three years starting at age three. There is limited evidence to support this recommendation. We postulate that annual hearing screening would be easier to manage and would have a worthwhile pick-up rate. Methods: In March 2019 we began a programme of annual hearing screening for all children (ages 0-16) with OI. We collected data on age, genotype, otoscopy findings, tympanometry findings, audiometric test results and subsequent outcomes for the first five years of our programme (2019-2024). Results: Nineteen children with OI participated in the screening programme. Only one abnormality was found: a unilateral mild hearing impairment with a type B tympanogram, suggesting middle ear effusion. This was present in year 2 of the programme but resolved by year 3. Conclusion: The screening programme has a low pickup rate (5 %) for new otological problems in the paediatric population. However, we believe that the low cost and small workload associated with the screening programme justifies continuing it until further conclusions can be drawn.
引用
收藏
页数:5
相关论文
共 25 条
[1]  
BERGER G, 1985, LARYNGOSCOPE, V95, P193
[2]  
Brittle Bone Society, 2013, Hearing loss and osteogenesis imperfecta
[3]   Hearing impairment and osteogenesis imperfecta: Literature review [J].
Carre, F. ;
Achard, S. ;
Rouillon, I ;
Parodi, M. ;
Loundon, N. .
EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2019, 136 (05) :379-383
[4]   Outcomes of transient evoked otoacoustic emission testing in 6-year-old school children: a comparison with pure tone screening and tympanometry [J].
Driscoll, C ;
Kei, J ;
McPherson, B .
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2001, 57 (01) :67-76
[5]   Bisphosphonate therapy for osteogenesis imperfecta [J].
Dwan, Kerry ;
Phillipi, Carrie A. ;
Steiner, Robert D. ;
Basel, Donald .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (10)
[6]   Hearing loss (in nonoperated ears) in relation to age in osteogenesis imperfecta type I [J].
Garretsen, AJTM ;
Cremers, CWRJ ;
Huygen, PLM .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1997, 106 (07) :575-582
[7]   Experience with bisphosphonates in osteogenesis imperfecta [J].
Glorieux, Francis H. .
PEDIATRICS, 2007, 119 :S163-S165
[8]   Cochlear implantation in a patient with osteogenesis imperfecta and otospongiosis [J].
Huang, TS ;
Yen, PT ;
Liu, SY .
AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1998, 19 (03) :209-212
[9]   Is it necessary to screen for hearing loss in the paediatric population with osteogenesis imperfecta? [J].
Imani, P ;
Vijayasekaran, S ;
Lannigan, F .
CLINICAL OTOLARYNGOLOGY, 2003, 28 (03) :199-202
[10]   Osteogenesis Imperfecta and hearing loss in the paediatric population [J].
Joseph, Judith K. ;
Maharaj, Shivesh H. .
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2021, 150